» Articles » PMID: 6321348

Toxoids of Pseudomonas Aeruginosa Exotoxin-A: Photoaffinity Inactivation of Purified Toxin and Purified Toxin Derivatives

Overview
Journal Infect Immun
Date 1984 Mar 1
PMID 6321348
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

For the preparation of greatly detoxified but highly immunogenic toxoids, two enzymatically active, low-toxicity derivatives of Pseudomonas aeruginosa exotoxin-A were further inactivated by photoaffinity labeling. These derivatives were formed during toxin purification, when a relatively crude toxin preparation was concentrated by ammonium sulfate precipitation and subsequently dialyzed. These derivatives, designated peak-1 protein (PK-1) and peak-2 protein (PK-2) were antigenically indistinguishable from native toxin, but had isoelectric points (5.00 and 4.90, respectively) that were different from that of the native toxin (4.95). Although the enzymatic activities and molecular weights of PK-1 and PK-2 were similar to those of native toxin, their toxicities were greatly reduced (ca. 500-fold). Photoaffinity labeling of fully active toxin-A, purified by a process which limits the formation of these derivatives, decreased its enzymatic activity (ca. 30-fold) and toxicity (ca. 100-fold). Likewise, photoaffinity labeling of purified PK-1 and PK-2 decreased their enzymatic activities and toxicities (ca. 30-fold and 100-fold, respectively) and, thus, yielded toxoids that were ca. 50,000-fold less toxic than unpurified native toxin. These toxoids were irreversibly detoxified and highly immunogenic during 9 months of storage at 4 degrees C.

Citing Articles

Prophylaxis of Pseudomonas aeruginosa infections in leukopenic mice by a combination of active and passive immunization.

Martinez D, Callahan 3rd L Eur J Clin Microbiol. 1985; 4(2):186-9.

PMID: 3924606 DOI: 10.1007/BF02013595.


In vivo studies with two phospholipase C fractions from Pseudomonas aeruginosa.

Berk R, Brown D, Coutinho I, Meyers D Infect Immun. 1987; 55(7):1728-30.

PMID: 3110070 PMC: 260587. DOI: 10.1128/iai.55.7.1728-1730.1987.


Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.

Cryz Jr S, Furer E, Sadoff J, Germanier R Infect Immun. 1986; 52(1):161-5.

PMID: 3082756 PMC: 262213. DOI: 10.1128/iai.52.1.161-165.1986.


Exotoxin A of Pseudomonas aeruginosa: substitution of glutamic acid 553 with aspartic acid drastically reduces toxicity and enzymatic activity.

Douglas C, Collier R J Bacteriol. 1987; 169(11):4967-71.

PMID: 2889718 PMC: 213894. DOI: 10.1128/jb.169.11.4967-4971.1987.


Sequence and transcriptional start site of the Pseudomonas aeruginosa outer membrane porin protein F gene.

Duchene M, Schweizer A, Lottspeich F, Krauss G, Marget M, Vogel K J Bacteriol. 1988; 170(1):155-62.

PMID: 2447060 PMC: 210620. DOI: 10.1128/jb.170.1.155-162.1988.

References
1.
Cryz Jr S, Friedman R, PAVLOVSKIS O, Iglewski B . Effect of formalin toxoiding on Pseudomonas aeruginosa toxin A: biological, chemical, and immunochemical studies. Infect Immun. 1981; 32(2):759-68. PMC: 351511. DOI: 10.1128/iai.32.2.759-768.1981. View

2.
Sanai Y, Morihara K, Tsuzuki H, HOMMA J, Kato I . Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase. FEBS Lett. 1980; 120(1):131-4. DOI: 10.1016/0014-5793(80)81063-5. View

3.
Morrissey J . Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem. 1981; 117(2):307-10. DOI: 10.1016/0003-2697(81)90783-1. View

4.
Fitzgerald D, Morris R, Saelinger C . Essential role of calcium in cellular internalization of Pseudomonas toxin. Infect Immun. 1982; 35(2):715-20. PMC: 351100. DOI: 10.1128/iai.35.2.715-720.1982. View

5.
Pollack M, Prescott R . Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization. J Infect Dis. 1982; 145(5):688-98. DOI: 10.1093/infdis/145.2.688. View